Higher-starting-dose protocols in patients with coronary artery disease and aspirin hypersensitivity

Ann Allergy Asthma Immunol. 2019 Nov;123(5):512-515. doi: 10.1016/j.anai.2019.08.013. Epub 2019 Aug 22.

Authors

Emily H Liang¹, Cy Y Kim², Javed Sheikh¹, Shefali A Samant³

Affiliations

¹ Department of Clinical Immunology and Allergy, Southern California Permanente Medical Group, Los Angeles, California.
² Department of Cardiology, Southern California Permanente Medical Group, Los Angeles, California.
³ Department of Clinical Immunology and Allergy, Southern California Permanente Medical Group, Los Angeles, California. Electronic address: Shefali.A.Samant@kp.org.

PMID: 31446131
DOI: 10.1016/j.anai.2019.08.013

No abstract available

Publication types

Letter

MeSH terms

Aged
Aspirin / administration & dosage*
Aspirin / adverse effects
Coronary Artery Disease / drug therapy*
Desensitization, Immunologic*
Drug Hypersensitivity / therapy*
Female
Humans
Male
Middle Aged

Substances

Aspirin